Form S-1
You describe yourself as a provider of a “leading software platform for digital media measurement and analytics.” Please provide the basis for your characterization that you have a leading software platform and describe how this leadership is defined and/or determined.Rest of the question
For example, it is not clear whether you are basing your leadership on objective criteria such as market share based on revenues for competing software platforms in your market category.
No reply letter found.
You describe your platform as being used to verify or analyze a variety of different channels, formats, and media devices. Please discuss any trends in revenues you have generated from the various channels, formats or media devices. For example, please clarify if any channel predominates and if you have derived a material amount of revenue from new channels such as CTV video ads or mobile video ads.
No reply letter found.
Please revise your disclosures to provide a quantitative and qualitative analysis of how your advertising revenues are impacted each period by the volume of purchased digital ads and the average cost per thousand impressions ("CPM") that you measure. This appears to be important and material information necessary to understanding your business and results of operations.Rest of the question
We refer you to Item 303(a)(3)(iii) of Regulation S-K and Sections III.D of SEC Release 33-6835.
No reply letter found.
You disclose that total revenue increased by $78.4 million primarily due to $26.8 million of growth in Advertiser Programmatic revenue from existing services, $19.8 million from the launch of Authentic Brand Safety at the end of 2018 and $14.2 million of growth from Advertiser Direct revenue from increased adoption of your services on social media platforms.Rest of the question
Please revise to explain in greater detail why your Advertiser Direct revenue and Supply-Side Customer revenue increased during the periods presented. In this respect, your disclosures do not appear to explain approximately $17.6 million of the increase in your total revenues.
No reply letter found.
We note from your disclosures on page F-39 that 12,044,940 stock options and 4,050,443 restricted stock units were granted during fiscal 2020. Please tell us the estimated fair value of your common stock at each grant date after January 1, 2020 through the date of the filing.
No reply letter found.
Please clarify the amount of revenue you generate through your programmatic partners and describe your agreements with them. We note that two programmatic partners facilitate payments exceeding 10% of your revenue. Please advise us whether you are substantially dependent on these partners, pursuant to Item 601(b)(10) of Regulation S-K. Certifications and Accreditations, page 74
No reply letter found.
Please provide more detail as to how the certifications and accreditations from the Media Rating Council and other bodies relate to your solutions and business model. Please describe the industry standards that you must adhere to and are auditing. Regulatory Matters, page 76
No reply letter found.
You reference new laws enacted in the United States, Europe and Brazil that may affect your business model. Please expand this section or your regulatory risk factors to discuss all material laws that regulate or limit your business.
No reply letter found.
You indicate that Providence Investor has nomination rights for six of your eight board members under the Existing Stockholders Agreement and that you will enter into a New Stockholders Agreement prior to the completion of the offering. Please identify all board members that have been nominated by Providence Investors or any other stockholder pursuant to rights under the stockholders agreements.
No reply letter found.
We note that you entered into a separation agreement with your former CEO Wayne Gattinella in February 2020. Please quantify the termination payments paid and stock options issued to Mr. Gattinella under this agreement. Further, please quantify the dollar amount of cash that you will pay Mr. Gattinella to repurchase his oustanding stock options by October 27, 2020.
No reply letter found.
Please identify the other parties to the Registration Rights Agreement that are related parties pursuant to Item 404(a) of Regulation S-K.
No reply letter found.
On pages 32 and 102, you reference your corporate opportunities provision of your certificate that will not obligate Providence Investor or their respective affiliates from pursuing such opportunities without first offering them to you until they were directed to do so in writing.Rest of the question
Please clarify whether this provision will be terminated automatically if Providence Investor no longer has a certain level of beneficial ownership. Further, please clarify whether Providence Investor has any portfolio companies that would be considered direct competitors to you in ad verification or software services.
No reply letter found.
You disclose that you will enter into a New Revolving Credit Facility in 2020. Please expand your disclosure to describe the material terms of this new credit facility when they are available. Further, since you disclose that the New Revolving Credit Facility will be paid in full at the close of the IPO, please clarify whether this new credit facility will be available for further borrowings in the future or if itRest of the question
will be replaced or terminated shortly after the IPO.
No reply letter found.
We note that for Advertiser Direct revenue, advertisers are provided access to the Company's platform through the Company's proprietary self-service software that provides the Company's customers with access to data on all their digital ads and enables them to make changes to their ad strategies.Rest of the question
Explain whether you directly collect the fees paid by your customers in these arrangements or whether your partners or other thirdparties collect and remit payments from your customers. Clarify your disclosures that indicate you face heighted payment risks since media agencies pay you on behalf of multiple customers who utilize them.
No reply letter found.
Please clarify your disclosures that indicate for those Supply-Side Customer revenues once the minimum guaranteed amount is achieved, any excess is recognized as earned based on a tiered pricing structure. Tell us whether the excess is recognized over time or at a point in time.
No reply letter found.
You disclose that revenue is recognized either over time or at a point in time, as the Company is providing services that the customer is continuously consuming and receiving benefit from or upon completion of the service. Please revise your revenue recognition policy to clarify the particular service arrangements that are recognized over time verses at a point in time.Rest of the question
Explain in greater detail your disclosures that indicate for those arrangements recognized over time, the Company utilizes an output method, based on the volume of impressions processed.
No reply letter found.
Please clarify your disclosures that indicate certain grants of stock options to executives contain a performance based vesting condition, whereby the award will vest upon the Company receiving cash amounts in excess of a predefined multiple of the initial investment amount of its majority owner.
No reply letter found.
We note that you completed several acquisitions during fiscal 2019 and 2018. Please tell us your consideration of disclosing a description of the qualitative factors that make up the goodwill recognized such as expected synergies from the business combinations. We refer you to ASC 805-30-50-1.
No reply letter found.
We note that you are subject to taxation in, and to the tax laws and regulations of, multiple jurisdictions as a result of the international scope of your operations and your corporate entity structure. Please tell us your consideration of providing a description of the tax years that remain subject to examination for foreign jurisdictions. We refer you to ASC 740-10-50-15.
No reply letter found.
Please identify your underwriters in your next submission or filing.
No reply letter found.
We note your response to prior comment 1 regarding the basis for your belief as to why you are a “leading software platform for digital media measurement and analytics” industry. Please briefly summarize your response in your prospectus summary; i.e., that you base your leadership on the breath of solutions you offer, your track record of innovation, and your accreditations.
No reply letter found.
Please disclose that affiliates of Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC will receive net offering proceeds in connection with the repayment of the New Revolving Credit Facility. Quantify the amounts they will receive.
No reply letter found.
Please expand your description of the Series A Preferred Stock private placement to clarify that 45,438,756 shares of your common stock held by your existing stockholders were exchanged for newly issued Series A Preferred Stock, which were then sold to new Private Placement Investors. Please quantify the number of shares and amount of proceeds received by Providence Investor.Rest of the question
Further, please quantify the number of shares and amount of consideration paid by Tiger Investor.
No reply letter found.
Please provide more details of the parties to the option cancellation agreements briefly described on page 7, in particular, members of management. We note, for example, it appears that a majority of these cancelled and cashed-out unvested performance-based options were related to your COO McLaughlin. Also, please clarify the purpose for cancelling these unvested options.
No reply letter found.
Please revise your description of your employment agreements to disclose the amount of equity awards that were specified by these agreements to be granted in 2020. We note, for example, that your agreements with Messrs. Zagorsky and McLaughlin specify grants of 6,500,000 stock options and 479,094 restricted stock units, respectively.
No reply letter found.
Please revise to disclose the stock options and restricted stock granted subsequent to January 1, 2021. You should also disclose the estimated fair value of your common stock on such grant dates.
to the Staff’s comment, the Registrant advises the Staff that it will expand its disclosure within “Management’s Discussion and Analysis of Financial Condition andRead in the reply
Results of Operations—Critical Accounting Policies and Estimates—Fair Value of Common Stock” in Amendment No. 1 to include the requested information. The revised disclosure that will appear in Amendment No. 1 is attached to this letter as Annex
A for the Staff’s review.
Your letter dated March 25, 2021 indicates that you issued stock options and RSUs subsequent to December 31, 2020. Considering the proximity of these issuances to the date your preliminary price range was determined, tell us how you considered using the preliminary price range as a factor in determining the fair value of your common stock on these issuance dates.Rest of the question
In this regard, please quantify factors that supports the significant difference between the 2021 grants valuation and the midpoint of Preliminary Price Range. Tell us whether changes in revenue and operating results supports this significant increase in valuation within a short time frame. In addition, clarify whether additional disclosure is warranted since it appears that the rapid changes in valuation of your shares of common stock was not solely attributable to changes in your financial condition or results of operations.
The Registrant acknowledges the Staff’s comment and advises the Staff that, as discussed below, the board of directors of the Registrant (the “Board”) did not consider the preliminary price range submitted to the Staff in the Registrant’s letter dated March 25, 2021 as a factor in its determination of the fair value of the Registrant’s common stock (the “Common Stock”) on January 28, 2021, February 17, 2021 orRead in the reply
March 11, 2021 (each, a “Grant Date”).Rest of the answer
Instead, at each Grant Date the Board, in consultation with its majority stockholder
Providence Equity Partners L.L.C., a leading private equity firm specializing in growth-oriented investments, determined the fair value of the Common Stock using a valuation formula based on the valuation ascribed to the Registrant in the Private Placement completed on November 18, 2020. On such date, an investor group led by Tiger Global Management, LLC invested in the Registrant at a total enterprise value (the “Total Enterprise Value”) that was determined based on arm’s length negotiations and resulted in a per share valuation of $17.22 (adjusted for the reverse stock split) as set forth in the Purchase Agreement
(defined below) entered into on October 27, 2020. The Private Placement and the Total Enterprise Value (and resulting per share value) ascribed to the Registrant by the investor group were the result of meetings with a number of sophisticated investors regarding a possible transaction and resulted in a clear “market value” for the Registrant’s securities which the Board viewed as the most objective evidence of fair value as of such date. The Total Enterprise Value represented an equity value of the Common Stock of approximately
14 times historical revenue for the last twelve months (“LTM Revenue”), less a discount for the lack of marketability of the
Common Stock (“Liquidity Discount”).
Based on the Total Enterprise Value from the Private Placement and the Board’s belief that it is customary and standard practice for high growth companies in the Registrant’s industry to use a revenue multiplier to value a company, the Board determined that the most appropriate representation of the value of the Common
Stock was to continue to attribute value based on LTM Revenue multiplied by 14, less a Liquidity Discount. The determination by the Board to maintain a LTM Revenue multiple of 14 at each Grant Date was reinforced by the fact that equity market trading prices (and thus valuation multiples) of public companies in similar or adjacent industries remained roughly equivalent, subject to normal market volatility, during the period from November 2020 to March 2021. The investment banks acting as placement agents in the Private Placement provided the Registrant with data that on October 27, 2020 valuation multiples of a group of comparable public companies ranged from 6 to
26 times estimated revenue, with a median valuation multiple of 12, based on equity market trading prices as of that date.
The Liquidity Discount was determined by the Board to be
15% for the valuation following the Private Placement, resulting in the following formula: Valuation = (LTM Revenue x 14) x 0.85. The
LTM Revenue utilized in the $17.22 per share valuation was the twelve months ended September 30, 2020 as that was the most recent month ended prior to the Registrant entering into a definitive agreement with the investor group for the Private Placement and the most recent historical financial information provided to the investor group. Utilizing this formula of (LTM Revenue x 14) x Liquidity Discount resulted in the following:
· At the January 28, 2021 Grant Date, the Board utilized this formula updated for LTM Revenue for the twelve months ended December 31, 2020 resulting in a per share valuation of $19.02 which it utilized as the exercise price per share (for stock options) and grant date share price valuation (for RSUs) on the Grant Date.
· At the February 17, 2021 Grant Date, the Board utilized this formula
(i) updated for LTM Revenue for the twelve months ended January 31, 2021 and (ii) decreasing the Liquidity
Discount from 15% to 10% to account for additional steps the Registrant took in furtherance of the anticipated initial public offering
(the “IPO”), resulting in a per share valuation of $20.31 which it utilized as the exercise price per share (for stock options) and grant date share price valuation (for RSUs) on the Grant Date.
· At the March 11, 2021 Grant Date, the Board did not issue any stock options but made one grant of RSUs to an incoming director in accordance with the Registrant’s director compensation policy for independent directors. The Board again utilized this formula (i) updated for LTM Revenue for the twelve months ended February 28,
2021 and (ii) decreasing the Liquidity Discount from 10% to 5% to account for additional steps the Registrant took in furtherance of the anticipated IPO including the anticipated public filing of the Form S-1 which took place on March 17, 2021. This formula resulted in a per share valuation of $22.11 which the Board utilized as the grant date share price valuation for the single grant of RSUs on such Grant Date.
The overall increase in value from the $17.22 per share valuation paid for by the investor group in the Private Placement (and utilized as the valuation for grants made in November and December of
2020) and the $22.11 per share valuation on the March 11, 2021 Grant Date represents an increase in value of 28.4% from December 31,
2020 to March 11, 2021. This 28.4% increase in value is consistent with the Registrant’s approximately 30% revenue growth for the two months ended February 28, 2021 as compared to the two-month prior year period. Over the same period, the S&P 500, Nasdaq
Composite and Nasdaq-100 increased 4.9%, 4.0% and 1.3%, respectively. In addition, the Board continued to evaluate public equity trading values of comparable public companies during the period from December 31, 2020 through March 11, 2021.
Subsequent to the March 11, 2021 Grant Date, the Registrant completed the audit of its financial statements for the year ended December 31, 2020 and publicly filed the Form S-1 with the
Commission. In anticipation of the IPO, the Board also received preliminary valuation expectations from the investment banks acting as underwriters in the IPO subsequent to March 11, 2021. These preliminary valuation expectations took into account not only the historical performance of the Registrant, but also future performance expectations projected by the research analysts at the investment banks, based on discussions with the Registrant as well as then-current public equity trading values of comparable companies, including companies in similar or adjacent industries and companies that had recently completed an IPO. These preliminary valuation expectations utilized a revenue multiple similar to the valuation formula utilized at each Grant Date by the Board, but excluded a liquidity discount considering the pending IPO. Further, unlike the valuation formula utilized at each Grant Date by the Board, the preliminary valuation expectations largely relied on a multiple of expected future revenues for the fiscal year ended December 31, 2022. The utilization of a multiple of projected
2022 revenue rather than historical revenue was the primary factor that resulted in a preliminary price range expectation that is higher than the valuation calculated by the Board at each Grant Date. Had the Board utilized projected 2022 revenue in its valuation formula described above (rather than LTM Revenue), the valuation at each of the February 17, 2021 Grant Date and the March 11, 2021
Grant Date would have been greater than the midpoint of the preliminary price range holding all other inputs constant, an inappropriate result.
In addition, in response to the Staff’s comment, the
Registrant advises the Staff that it will expand its disclosure within “Management’s Discussion and Analysis of Financial
Condition and Results of Operations—Critical Accounting Policies and Estimates—Fair Value of Common Stock” in Amendment
No. 1 to provide investors with additional detail on the formula the Registrant used to determine fair value at each Grant Date subsequent to December 31, 2020 and advise investors that the trading price of the Common Stock following the IPO may fluctuate significantly based on a number of factors. The revised disclosure that will appear in Amendment No. 1 is attached to this letter as Annex A for the Staff’s review.
You disclose that you "recorded the exchange of common stock for preferred stock as Treasury Stock at cost in the Consolidated Balance Sheets." Please cite the accounting literature that supports your accounting. Clarify whether you believe that fair value of the shares of preferred stock and common stock are equal.Rest of the question
It would seem that the preferred shares with its preferential rights would have a fair value that would exceed that of the shares of common stock. If there is an excess amount, describe how you are accounting for that amount. Conversely, if these fair values and the shares are the same, explain why the exchange would not be recorded at the historical cost of the shares of common stock since it is an exchange of similar securities.
provides further information. On October 27, 2020, the Registrant entered into a Series A Preferred Stock Purchase AgreementRead in the reply
(the “Purchase Agreement”) to issue shares of its Series A Preferred Stock (the “Preferred Stock”) at a price of $5.7371 per share (the “Original Issue Price” or “OIP”) to new unrelated investors (the “New Investors”).
Simultaneously, in accordance with the terms of the Registrant’s stockholders agreement (the “Stockholders Agreement”) in effect as of October 27, 2020, the Registrant offered existing holders (the “Existing Investors”) of the Common Stock the right toRest of the answer
exchange their shares of Common Stock for shares of the Preferred Stock in a 1:1 ratio (the “Exchange”). Any
Existing Investors that participated in the Exchange sold their newly received shares of the Preferred Stock to the New Investors at the
OIP.
The Registrant accounted for the Exchange with the Existing
Investors as a repurchase of the Common Stock held by the Existing Investors in exchange for the issuance of Preferred Stock to the Existing
Investors, which was ultimately sold to the New Investors. The fair value attributed to the Common Stock that was repurchased was not equal to the fair value attributed to the Preferred Stock that was issued, but the difference was deemed to be insignificant. Although the difference in fair value was deemed to be insignificant, the Common Stock and Preferred Stock were not considered similar securities due to difference in rights associated with each class of shares.
The difference between the fair value of the Common Stock and the fair value of the Preferred Stock was approximately 2%, contemplating the value indicated by the Registrant’s 409A as of
September 30, 2020 of the Common Stock of $5.61 ($16.83 adjusted for the reverse stock split) and the OIP of the Preferred Stock as of October 27, 2020. Holders of the Preferred Stock have preference in liquidation and certain other rights that differ from the rights of the holders of Common Stock (i.e., the Common Stock and Preferred Stock are not similar securities). However, since (i) the holders of the Preferred Stock were not entitled to vote for the election of directors or granted separate board designation rights, (ii) the
Preferred Stock is mandatorily converted to Common Stock upon an initial public offering (as described in Note 13 Stockholders’
Equity, page F-40 of the Consolidated Financial Statements) and (iii) the offering was expected to be completed in approximately six months, there was not a significant difference in fair value at the time of the Exchange.
In evaluating the accounting considerations for the difference between the fair value of the Preferred Stock and the fair value of the Common Stock at the time of the Exchange, the Registrant considered
ASC 505-30-30-2 and concluded that the excess of the repurchase price per share of the Common Stock over the then current market price was not significant and therefore, accounted for the repurchase as a treasury stock transaction with the repurchase price allocated entirely to the repurchased shares. The subsequent issuance of the Preferred Stock, a different class of shares from the Common Stock, to the Existing
Investors was recorded at the OIP, the then fair market value.
ASC 505-30-30-2 states (emphasis added):
An allocation of repurchase price to other elements of the repurchase transaction may be required if an entity purchases treasury shares at a stated price significantly in excess of the current market price of the shares. An agreement to repurchase shares from a shareholder may also involve the receipt or payment of consideration in exchange for stated or unstated rights or privileges that shall be identified to properly allocate the repurchase price.
Also in this review: company letter, Apr 8, 2021